ClinicalTrials.gov
public full text
Public Domain
iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML
This study will use droplet digital PCR (ddPCR) method to quantify and track peripheral blood plasma mutant allele frequency (MAF) in MDS and AML patients before, during and after chemotherapy treatment. Quantification of MAF from fingersticks and saliva samples will also be performed to determine feasibility of obtaining adequate circulating tumor DNA (ctDNA) for ddPCR.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study to Determine the Clinical Significance of Molecular Detection of Breast Cancer in the Blood of Stage IV Breast Cancer Patients#1112782
- Prognostic Markers for a Better Follow-up in Head and Neck Cancer.#1009796
- Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib#1085350
- Cultured Circulating Tumor Cells in Prostate and Other Cancers#1124769
- Studying Biomarkers in Blood Samples From Patients With Invasive Cervical Cancer#913389
Record · ID 891506
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive